TD Cowen Initiates Coverage On Yarrow Bioscience with Buy Rating

Benzinga Newsdesk www.benzinga.com Neutral 80.8%

Neg 0% Neu 80.8% Pos 0%

TD Cowen analyst Stacy Ku initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating.

Comments

No comments yet. Be the first!